Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2022-03-18 Annual Report
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for Solco Biomedical for the fiscal year 2021. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. This document represents the full annual financial reporting package, which corresponds to the 10-K category in the provided schema. FY 2021
2022-03-18 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a regulatory filing submitted to the Financial Services Commission/Korea Exchange. It contains information regarding the solicitation of proxies for the upcoming Annual General Meeting (AGM), including voting methods, director/management information, and financial statements for approval. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-14 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a regulatory filing submitted to the Financial Supervisory Service (FSS) in South Korea. It contains information regarding the solicitation of proxies for the company's Annual General Meeting (AGM), including the agenda, voting procedures, and financial statements for the purpose of shareholder approval. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-03-14 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Solco Biomedical Co., Ltd. It details the meeting date, location, agenda items (such as approval of financial statements and director compensation), and information regarding electronic voting. This document is a standard proxy statement/notice sent to shareholders to inform them of an upcoming meeting and solicit their votes, which fits the definition of a Proxy Solicitation & Information Statement.
2022-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It includes details about the meeting date, the purpose of the solicitation, and proxy voting procedures. While it contains financial statements, these are provided as supplementary information for the shareholders' decision-making process regarding the AGM agenda, not as a standalone annual report. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2022-03-08 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Solco Biomedical. It outlines the date, location, and agenda items (financial statement approval, director/auditor compensation limits) for the upcoming Annual General Meeting. As it provides information to shareholders regarding an upcoming meeting and requests their participation/votes, it falls under the category of Proxy Solicitation & Information Statement.
2022-03-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.